QAIAx Clinical Trial: AGI Alternative Sentencing & Reality Pro-Social Dating (Veterans First for America)

QAIAx Clinical Trial: AGI Alternative Sentencing & Reality Pro-Social Dating (Veterans First for America) RICHMOND, Va., July 12, 2026 (GLOBE NEWSWIRE) -- QAIAx Microcities Clinical Trial provided an new patent filing update regarding the development of an open-source military-grade artificial general intelligence (AGI) platform named the QAIAx Cool World (ISAC) platform. This platform enables real-life holoportation of humans, hard objects, holographic agents, and omni-AI humanoids, which can be partially or fully controlled by human users. It operates under a pioneering public-use technology license aimed at regulating AGI, ensuring data privacy, and maintaining legal compliance within the context of an AI smart health cities clinical trial. The technology introduces a 90/10 hybrid human-AI civic workforce model, facilitating advanced virtual reality for social dating, professional conferencing, and alternative prison sentencing. Key components include the AI Wat series "Beam Bot" and the “AVK,” an AI suit that creates a holoportation experience with haptic feedback, marking a significant advancement in the AGI Robotics Sector and the AI Era.

AI Alternative Sentencing & Psychiatric Treatment

The architecture introduces non-medicinal, psychiatric rehabilitation tools built for first-time, quasi-criminal, non-violent offenders, and administrative violators:

Frontier Hardware & The Cool World Dating Game

The platform integrates advanced peer-to-peer interactive environments using everyday consumer tech alongside proprietary hardware:

QAIA Pro License & Future Mars Pilot

Civic operations, specialized training, and administrative roles within the smart city require a QAIA Pro License. Professional users—including legal case managers, virtual educators, criminal attorneys, healthcare providers, and civic technicians—use this credential to manage automated networks. Similarly, the clinical trial’s resident patients will be given trainable AI-Me robots (“QAIA Minime”) to master technical certifications, mirroring the historic IT licensing booms of the 1990s that were presented by PC/Internet Era pioneers such as IBM and Microsoft.

Looking forward, developers are actively designing the Just Like Mars Mission (QAIAx v3.0—called “QIII”; an upscaled version of QAIAx’s second-generation of AI City Hall Project—despite no activities with Space Exploration Technologies Corp., and only passive NASA-affiliate program initiatives that paused during the ‘25 federal shutdown. QIII prototype pilot is anticipated to run as its own clinical trial with an anticipated launch later in 2027. USPTO filings for QIII provide details about a continuum of original QAIAx build as an isolated, intranet off-grid testing environment, sending omni-AI humanoids to outer-world destinations to conduct human managed activities.

Clinical Trial Information

Prospective corporate sponsors, institutional partners, and patients seeking to join the active clinical trial waiting list can submit formal regulatory inquiries through the official ClinicalTrials.gov (PRS-NCT07661823) portal, or visit www.vetsrecovery.org.